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ABSTRACT 
ESCHERICHIA COLI 2-OXOGLUTARATE DEHYDROGENASE 
MULTIENZYME COMPLEX: E1 AND E2 SUBSTRATE SPECIFICTY, E1 
CARBOLIGASE ACTIVITY, AND E2 INTERCHAIN SUCCINYL TRANSFER  
 
by 
Da Jeong Shim 
Escherichia coli (E. coli) 2-oxoglutarate dehydrogenase multienzyme complex (OGDHc) 
contains three components: a thiamin diphosphate (ThDP) dependent 2-oxoglutarate 
dehydrogenase (E1o), a dihydrolipoylsuccinyl transferase (E2o), and a dihydrolipoyl 
dehydrogenase (E3). The first two components carry out the principal reactions for 
succinyl CoA formation while the third one reoxidizes dihydrolipoamide to lipoamide.  
This mechanism is similar to other 2-oxoacid dehydrogenase complexes, including 
pyruvate dehydrogenases (PDHc) and branched-chain dehydrogenases.  
E1o of the E. coli OGDHc was engineered to accept unnatural substrates.  The 
natural substrate for E1o is 2-oxoglutarate (2-OG) and the enzyme was engineered to 
accept substrates lacking the 5-carboxylate group, 2-oxovalerate (2-OV). E1o was 
subjected to saturation mutagenesis at His260 and His298. The His298Asp E1o variant 
was identified in the screen to accept the unnatural substrate.  In addition, it was 
discovered that His260 is required for substrate recognition, but His298 could be replaced 
with hydrophobic residues of similar molecular volume. To interrogate whether the 
second component would allow synthesis of acyl-coenzyme A derivatives, hybrid 
complexes consisting of recombinant components of OGDHc (o) and pyruvate 
dehydrogenase (p) enzymes were constructed, suggesting that a different component is 
the “gatekeeper” for specificity for these two multienzyme complexes in bacteria, E1p for 
pyruvate but E2o for 2-OG.  
 
Although His298Asp E1o accepted 2-OV, reconstitution of the variant with E2o 
and E3 did not generate NADH in the overall reaction using 2-OV.  Hence, the reaction 
may be hindered in the E2o component. E2o consists of an amino-terminal lipoyl domain 
(E2oLD, 12 kDa), followed by a peripheral subunit binding domain (4 kDa) and a 
succinyltransferase domain (E2oCD, 28 kDa). There are two possibilities for the failure 
to form NADH. Reductive acylation is not occurring in the E2oLD or acyl transfer to 
CoA is not taking place in E2oCD.   His298Asp E1o, E2oLD, and 2-OV form butyrylated 
E2oLD, which was shown by electrospray ionization mass spectrometry.  Therefore, the 
E2oCD domain necessitates optimization to produce acyl-CoA derivatives.  
Succinyl transfer to the CD domain may occur through an intrachain or interchain 
pathway.  The E2oLD and E2o with a lysine to alanine substitution at position 43 
(E2oK43A) were created by site directed mutagenesis. It is clearly shown that E2oLD 
was capable of rescuing the crippled E2oK43A variant by measuring the NADH 
production in the overall reaction. Therefore, an interchain mechanism is likely between 
two different E2o subunits. 
ThDP-dependent enzymes have the potential to be used for chemical synthesis. 
These enzymes share a common feature in that they catalyze carboligase reactions. E1o 
catalyzed carboligation products with a variety of substrates and acceptors that vary in 
the size and functional groups. Structures of the products were confirmed with NMR.  In 
addition, high enantiomeric excess (ee) values were found for the products as shown by 
chiral gas chromatography and CD spectroscopy.  Finally, it was shown that E1o is 
capable of forming stable esters.  This is important because when the carboligase 
reactions produce -ketoacids, these products are unstable and prone to decarboxylation. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 2-Oxoglutarate Dehydrogenase Multienzyme Complex from Escherichia coli 
The 2-oxoglutarate dehydrogenase multienzyme complex (OGDHc) catalyzes the 
rate-limiting step in the citric acid cycle (Figure 1.1) [1, 2], which is the common pathway 
for the oxidation of fuel molecules, including carbohydrates, fatty acids and amino acids. 
In addition, neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease 
[3-5], have been linked to inactivation of OGDHc in highly active tissues. OGDHc 
catalyzes the formation of succinyl coenzyme A (CoA) according to Equation 1.1. 
 
Figure 1.1 Citric Acid Cycle. 
 
Source: Jeremy M. Berg, John L. Tymoczko, and Lubert Stryer “Biochemistry” fifth edition, Freeman, pp. 
478. http://www.ncbi.nlm.nih.gov/books/NBK22427/figure/A2403/?report=objectonly.
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 The OGDHc is composed of multiple copies of three components (Figure 1.2) 
[6-9]: (1) A thiamin diphosphate (ThDP) dependent 2-oxoglutarate dehydrogenase (E1o, 
105 kDa, EC 1.2.4.2, Figure 1.2 A). (2) A dihydrolipoylsuccinyl transferase (E2o, 45 kDa, 
EC 2.3.1.6, Figure 1.2 B and C) and (3) A dihydrolipoyl dehydrogenase (E3, 55 kDa, EC 
1.8.1.4). The first two components carry out the principal reactions for succinyl-CoA 
formation while the third one reoxidizes dihydrolipoamide E2 to lipoamide E2. This 
mechanism is similar to other 2-oxoacid dehydrogenase complexes, including pyruvate 
dehydrogenase (PDHc) and branched-chain dehydrogenase (BCDHc) (Equation 1.2-1.5).  
 
A.                                      B.                                  C. 
   
Figure 1.2 Structure of E1o and E2o Components. A: Ribbon Diagram of Truncated E1o. 
Histidine 260 and 298 are Shown as Red Spheres. B: Ribbon Diagram of the Lipoyl 
Domain of E2o. Lys43 is Shown as Sticks. C: Ribbon Diagram of E2o Catalytic Domain. 
The Carboxyl-binding Residue (Ser333) is Shown in Magenta. The Carboxylate-binding 
Group (His348) is Shown in Red.  
 
 
2-oxoglutarate + CoA + NAD
+
 → succinyl CoA + CO2 + NADH (1.1) 
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 The E1o component catalyzes the initial decarboxylation of the 2-oxoglutarate, 
using ThDP as a cofactor (Equation 1.2), and then reductively succinylates a lipoyl group 
bound to a lysine residue in E2o (Equation 1.3, Figure 1.2 B). E2o is a succinyl transferase 
responsible for transferring the succinyl group to CoA (Equation 1.4), and the 
dihydrolipoyl group left on E2o finally reoxidized to the dithiol ring by the flavoprotein 
E3, with NAD
+
 as the ultimate electron acceptor (Equation 1.5). The mechanism of 
OGDHc and the role of ThDP are shown in Scheme 1. 
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Scheme 1 Mechanism of 2-Oxoglutarate Dehydrogenase Complex of E. coli. 
 
 The OGDHc is organized about a core consisting of the oligomeric E2o [10-12], 
which are bound to multiple copies of E1o and E3. The E2o component is a modular 
protein that is composed of one, two, or three amino-terminal lipoyl domains, followed by 
an E1o and/or E3-binding domain, and then by carboxyl terminal catalytic domain. The 
domains are connected by linker segments [13-15]. In E. coli, E2o contains only one lipoyl 
domain, subunit binding domain, and catalytic domain (Figure 1.3). The E2o is organized 
either as a 24-mer with octahedral symmetry or a 60-mer with icosahedral symmetry 
depending on the organism. The optimal stoichiometry for the E. coli complex has been 
estimated at 12 E1o: 24 E2o: 12 E3 (3120 kDa) [16]. The E3 component is identical in 
OGDHc and the pyruvate dehydrogenase complex (PDHc) [17, 18]. PDHc is also part of 
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the citric acid cycle. PDHc shares a similar mechanism with OGDHc, but it utilizes 
pyruvate as a substrate.  
 
 
Figure 1.3 The E. coli E2o Component. 
 
1.2 Substrate Specificity of OGDHc 
Substrate specificity of OGDHc is regulated by E1o component as well as E2o. E1o is 
responsible for recognition and decarboxylation of 2-oxoglutarate (2-OG) (Equation 1.2, 
Figure 1.4 A). The crystal structure for a truncated E1o from E. coli (Figure 1.2 A) has 
been reported [6]. Site directed mutagenesis and kinetic studies indicated that His260 and 
His298 were positioned to interact with the distal carboxylate of 2-OG (Figure 1.5).  
 
 
O
HO
O
O
OH
O
O
OH
A. B.
2-oxoglutarate (2-OG) 2-oxovalerate (2-OV)  
Figure 1.4 Substrates for OGDHc. A: Structure of 2-Oxoglutarate. B: Structure of 
2-Oxovalerate. 
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Figure 1.5 Stereo View Showing Histidines and a Few Other Residues near the Active Site 
of the E. coli 2-Oxoglutarate Dehydrogenase Multienzyme Complex E1 Component, 
Showing Their Proximity to the Reactive Center C2 Atom on Thiamin diphosphate 
(ThDP). Coordinates for the Protein Atoms were Obtained from the PDB entry 2JGD, 
which is Described in [6]. 
 
E2o substrate recognition occurs in two stages. First, E1o reductively succinylates 
the prosthetic group lipoic acid that is covalently attached to Lys43 in the lipoyl domain 
(Equation 1.3, Figure 1.2 B). An important interaction is between the E1 component and 
the loop region of E2o. Key residues include 7-20 and Thr42 [17]. Second, the catalytic 
domain (CD) of the E2o component catalyzes the transfer of a succinyl group from the 
S-succinyldihydrolipoyl moiety to coenzyme A. Computational modeling and sequence 
alignment studies of all known E2’s indicate that in E2o serine residues 330 and 333 are 
located near the proposed succinyl-binding site. Ser333 may hydrogen bond with the 
carboxyl group of the substrate. His348 is conserved in all E2’s, and it is positioned to 
interact with the carboxylate oxygen of the succinyl group (Figure 1.6) [7]. The origin of 
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substrate specificity remains unclear. It will be determined that the contribution of His260 
and His298 for substrate specificity. In addition, the “gate-keeper” will be determined. For 
example, does E1 or E2 control the substrate specificity?  
 
 
  Figure 1.6 The Stereo View of the Substrate Binding Sites on E2o Component [7]. 
 
1.3 Applications of OGDHc 
1.3.1 Green Chemical Synthesis with OGDHc 
Enzymes catalyze reactions under mild conditions in aqueous solutions, and they can also 
provide tools for environmental friendly chemical synthesis [2, 19-21]. However, 
biocatalysts often display poor catalytic activity for unnatural substrates. This is especially 
true for enzymes that have specific functions across many species [22]. In addition, 
enzymes are readily denatured under typical reaction conditions, which include organic 
solvents and elevated temperatures. Hence, an efficient strategy is necessary to engineer 
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enzymes, and semi-rational methods offer an effective approach to engineer and optimize 
catalytic activity [23]. 
 OGDHc has the potential to synthesize coenzyme A-linked thiol esters, comprising 
a large class of metabolically relevant compounds participating in many metabolic 
pathways. Also, thiol esters are important as organic synthetic intermediates by virtue of 
the ‘high energy’ bound between the carbonyl group and the sulfur atom, and they can be 
converted to a number of carboxylic acid derivatives [24]. It can also be used for peptide 
coupling [25-27], acyl transfer [28, 29], protecting groups for thiols [30], and also as 
coupling partners in organometallic reactions [31-33]. They are also key intermediates in 
various biological systems [34] and find broad applications in medicinal chemistry [35].  
 There are many traditional methods for the formation of thiol esters, such as, the 
direct coupling of a thiol with the parent carboxylic acid and an activating agent [36, 37], 
the coupling of a thiol with an acid chloride [38], or reaction of thiol with an acid anhydride 
[39] and the coupling of thiocarboxylates with arenediazonium salts [40]. However, there 
are limitations of these methods such as difficulties in handling thiols and thioacids and 
also the availability of starting materials. Thus, it is necessary to find a novel method for 
such highly useful organic products. 
 It is proposed that the synthesis of thiol esters using a multi-enzymatic pathway to 
convert a racemic amino acid precursor RCH(NH2)COOH, which are readily available, to 
thiol esters RC(=O)SR’, with a broad range of R and R’ groups under mild neutral aqueous 
conditions (Figure 1.7, reaction 1). First, a broad-spectrum racemase (EC 5.1.1.10) will 
catalyze the stereochemical inversion around the asymmetric carbon atom (Figure 1.7, 
Reaction 2). Next, a transaminase (EC 2.6.1.1) will catalyze the removal of the amino 
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group to yield a 2-oxo acid (Figure 1.7, Reaction 3). The product will be decarboxylated by 
E1 (Figure 1.7, Reaction 4), and E2 transfers to acyl group to a thiol (Figure 1.7, Reaction 
5). 
 E1o will be engineered to accept non-natural substrate. E1o will be converted to 
accept 2-oxovalerate over 2-oxoglutarate. The substrates are similar, but the carboxylate is 
substituted by a methyl group (Figure 1.4). 
 
 
Figure 1.7 A Method to Convert a Racemic Amino Acid Precursor to Thiol Esters. 
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1.3.2 Carboligase Reactions of OGDHc 
The evolutionary pressure for optimized and efficient turnover has resulted in enzymes 
with tight substrate specificities. However, most enzymes catalyze off pathway side 
reactions caused by substrate and catalytic promiscuity [41-43].  
 This promiscuity has become very popular in point of redesigning and optimizing 
enzymatic activities for industrial application [44, 45]. There are huge challenges to make 
an existing enzymatic side reactions (low activity) become higher than its original activity 
or introduce desired new activity without spoiling the original enzymatic activity [46].  
 The thiamin dependent enzymes, pyruvate decarboxylase and benzoylformate 
decarboxylase, are well known enzymes for biocatalytic applications owing to their 
inherent substrate and catalytic promiscuity. In addition to the decarboxylation of 
2-oxoacids, ThDP-dependent decarboxylases, including the first components of the 
2-oxoacid dehydrogenases catalyze so-called carboligation side reactions to form C-C 
bonds [47, 48]. Conversion of the substrate 2-oxo acids involves a series of 
substrate-cofactor conjugates as reaction intermediates (Scheme 1). Initially, addition of 
the reactive C2 atom of the cofactor thiazolium ring to the carbonyl carbon of 2-oxoacids 
yields the pre-decarboxylation intermediate C2-lactyl-ThDP. Subsequent 
decarboxylation produces the resonating C2-carbanion/enamine forms of 
C2-hydroxyethylidene-ThDP, a central and highly reactive intermediate. A carboligase 
side reaction takes place when the nucleophilic C2-carbanion/enamine adds to 
electrophilic aldehydes or ketones [19, 47].  
 ThDP-dependent enzymes have the potential to be used for chemical synthesis. 
Carboligation is the native activity for several enzymes, but it is a side reaction for nearly 
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all 2-oxo acid decarboxylases [19]. Previously several active site variants were created in 
yeast pyruvate decarboxylase (YPDC) from Saccharomyces cerevisiae, the E1 subunit of 
E. coli PDHc (E1p) [49] and PDHc from Zymomonas mobilis [46]. Those enzyme 
complexes produced different enantiomeric selective carboligase products using amino 
acid analogs as the substrates [48, 50]. It can be used to synthesize important chemical 
intermediates such as chiral 2-hydroxy ketones. The 2-hydroxy ketone products produced 
from this activity afford versatile, exchangeable chemical groups in the immediate vicinity 
of a chiral center. Valuable potential building blocks for the synthesis of numerous 
compounds with pharmacological importance include: the tranquilizer and smoking 
cessation drug bupropion [51], the anti-allergic drug cytoxazon [52], and the 
multidrug-pump inhibitor 5-methoxyhydnocarpin [53]. Furthermore, carboligase products 
can be used to treat health issues such as Alzheimer’s disease because they can inhibit the 
citric acid cycle [49, 50].  This research will explore the possibility of using E1o for 
carboligase reactions with 2-OG and various acceptors.  
  
1.4 Importance of Recombinant 2-Oxoglutarate Dehydrogenase Complex 
In 1985, the activity of OGDHc of E. coli was measured by Steginsky et al [54]. Their 
results showed that OGDHc utilizes pyruvate as a poor substrate, with an activity of 0.083 
units/mg protein compared with 22 units/mg protein for 2-OG. Activity with pyruvate 
could result from the presence of contaminating PDHc or acceptance of pyruvate as a poor 
substrate 2-OGDHc. They concluded that activity on pyruvate cannot be explained by 
either of the above, but rather that the 2-OGDHc is a hybrid complex containing a 
significant amount of the E1p component from E. coli PDHc. They separated those two 
  
12 
 
enzyme complexes using their isoelectric precipitation (PI). There was a problem to 
separate those two enzyme complexes because they have very similar PIs. These results 
did not provide a clear origin of substrate specificity. Hence, it is important to use 
recombinant proteins to ensure there is no contamination. This is necessary to understand 
the true origin of substrate specificity of the complex. 
 In this work [55], all of the recombinant E1p, E2p, E1o, E2o and E3 components 
were prepared as pure enzymes from E. coli. Each component will be reconstituted to 
measure its overall activity so that the origin of substrate specificity can be clearly 
elucidated. 
 
1.5 Interchain Succinyl Transfer in the E2 Component of the E. coli 2-Oxoglutarate 
Dehydrogenase Complex 
The structural core of the complex is provided by E2, with E1 and E3 bound around the 
periphery [14, 15, 56, 57]. The E2 chains are highly segmented, from the N-terminus, one 
to three lipoyl domains (LD, approx. 9kDa), a peripheral subunit-binding domain (PSBD, 
approx. 4kDa) and a catalytic domain (CD, approx. 28kDa) (Figure 1.3) [15, 58]. The E2o 
chain of 2-OGDHc contains a single LD and an assembly of 24 separate CD arranged with 
octahedral symmetry forms the core of the complex [7, 17], and it is possible that 
interchain acyl transfer would take place between an LD of one chain and a CD of another 
one, with the mobility of the LD provided by flexible alanine and proline rich extended 
linkers.  
 Recently, the Jordan group at Rutgers investigated whether the acetyl group is 
passed from the LD to the CD in an intra- or interchain reaction using E2p from E. coli 
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PDHc, which contains three lipoyl domains [59]. They demonstrated interchain transfer of 
the acetyl group by providing mass spectrometric and kinetic evidences. These data 
provided a model for the presence of multiples of three chains in all E2 components, and 
their assembly in bacterial systems. They created a hybrid single lipoyl domain instead of 
using the natural three-lipoyl domain E2 component. Although it was shown that the 
activities of one-LD E2p and three-LD E2p are virtually the same, it is possible that the 
mutated single LD E2p can affect the results. Therefore, it is better to use native E2 
component itself. As previously mentioned, the E2o from E. coli has only a single lipoyl 
domain. This system is simpler and it should be easier to determine if interchain transfer is 
a possible mechanism. 
 
1.6 Research Objectives in This Dissertation 
1. Elucidate the origin of substrate specificity in E. coli OGDHc and PDHc. 
2. Determine the versatility of E. coli E1o for carboligase reactions. 
3. Investigate interchain succinyl transfer of the E2o component of E. coli OGDHc.
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CHAPTER 2 
ALTERING SUBSTRATE SPECIFICITY OF THE Escherichia coli E1o OF 
2-OXOGLUTARATE DEHYDROGENASE COMPLEX  
 
2.1 Introduction 
The factors that govern specificity of 2-oxoglutarate dehydrogenase multienzyme complex 
(OGDHc) towards its 5-carboxyl substituent will be elucidated. The goal is to synthesize 
acyl-coenzyme A analogs, comprising a large class of metabolically relevant compounds 
participating in many metabolic pathways.  
According to the x-ray structure of E1o, there were three His residues (His260, 
His298 and His729) positioned near the thiazolium ring of thiamin diphosphate (ThDP) [6] 
(Figure 2.1), and substitution of His260 and His298 to alanine drastically reduced the 
activity. The results suggested that the histidine side chains interacted with the distal 
carboxylate of 2-oxoglutarate (2-OG) [6]. 
 
Figure 2.1 Active Site of E1o Showing Mg
2+
, ThDP, and the Inhibitor Oxaloacetate [6]. 
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Saturation mutagenesis libraries of His260, His298, and His260/His298 were 
created and screened for activity towards 2-OG, and an unnatural substrate, 2-oxovalerate 
(2-OV), in which a nonpolar methyl group replaced the charged carboxylate (Figure 2.2). 
 
O
HO
O
O
OH
O
O
OH
A. B.
2-oxoglutarate (2-OG) 2-oxovalerate (2-OV)  
Figure 2.2 Substrates for OGDHc. A: Structure of 2-Oxoglutarate. B: Structure of 
2-Oxovalerate. 
 
Several E1o variants were isolated, some with the ability to decarboxylate 2-OV. 
The E1o variants created by the His260 and His298 substitutions were shown to be 
functionally competent according to their ability to produce a ThDP-bound 
pre-decarboxylation intermediate [60]. Next, it was determined whether the second E2o 
component would allow synthesis of acyl-coenzyme A derivatives.  Hybrid complexes 
consisting of recombinant components of the E. coli 2-oxoglutarate (o) and pyruvate 
dehydrogenase (p) enzymes were constructed (the E3 component is common to both) and it 
was demonstrated that E1p imparts specificity for acetyl-CoA formation from pyruvate, 
but E2o controls specificity for succinyl-CoA formation by OGDHc in Gram-negative 
bacteria.  
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2.2 Materials 
Thiamin diphosphate (ThDP), dithiothreitol, and isopropyl--D-thiogalactopyranoside 
(IPTG) were from U.S. Biochemical Corp.  NAD
+
, coenzyme A (CoA), and 2, 
6-dichlorophenolindophenol (DCPIP) were from Sigma-Aldrich. Restriction enzymes 
were purchased from Invitrogen. Primers were procured from Fisher. 
 E. coli strain JW0715 containing the plasmid pCA24N encoding the OGDHc-E1 
(E1o) component and AG1 cells containing pCA24N plasmid encoding OGDHc-E2o [both 
ASKA clone (-)] were obtained from National Bio Resource Project (NIG, Japan). 
 
2.3 Methods 
2.3.1 Site Directed Saturation Mutagenesis 
Site-directed saturation mutagenesis libraries were constructed using a modified 
QuikChange procedure for His260, His298, and the doubly substituted His260/His298 
variants.  A typical 50 L reaction contained 10x PfuUltra buffer, dNTP (0.2 mM) and 
PfuUltra DNA polymerase (1 unit), pCA24N encoding the E1o subunit, and randomization 
primers are shown in Table 2.1. 
 
Table 2.1 List of NNS Primers 
  
No Site 5’                                     NNS Primers                                               3’ 
1 H260X-F CGGGATGGCGNNSCGTGGTCGTC 
2 H260X-R GACGACCACGSNNCGCCATCCCG 
3 H298X-F CGTGAAATACNNSATGGGCTTCTCG 
4 H298X-R CGAGAAGCCC ATSNNGTATTTCACG 
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The PCR reaction consisted of 18 cycles at 95 °C for 30 s, 55 °C for 1 min and 68 
°C for 10 min. After the PCR, DpnI was added to the reaction mixture and then PCR 
product was transformed into E. coli DH5 cells. In order to randomize both positions, the 
template was the PCR product from H298 randomization and primers were H260X-F and 
H260X-R (Figure 2.3). 
 
Figure 2.3 PCR Strategy for Creating Site Directed Saturation Mutagenesis for H260X, 
H298X, and H260X/H298X. 
 
2.3.2 E1o Specific Assay 
The E1o specific activity assay was adapted to measure activity in whole cell lysates in 
96-well microtiter plates (Figure 2.4). The plasmids containing the mutant genes for 
H260X, H298X or H260X/H298X were transformed into DH5 competent cells and 
plated onto LB agar plates containing chloramphenicol (100 g/mL). Single colonies were 
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picked into 96-well microtiter plates containing 200 L LB medium and chloramphenicol 
(100 g/mL). The first column contained wild-type E1o as control. The plates were 
incubated overnight at 37 °C in the shaker at 250 rpm. The master plates were duplicated 
using 96-slot pin multi-blot replicator and it was stored at 4 °C. The duplicate plates 
contained 200 L LB medium supplemented with chloramphenicol (100 g/mL), MgCl2 
(2 mM), thiamin hydrochloride (1 mM) and IPTG (1 mM).  The resulting plates were 
incubated overnight at 37 °C with shaking at 250 rpm.  Next, the plates were centrifuged 
(1600 g) and the medium was discarded. The cell pellets were resuspended with 200 L 
NaH2PO4 (100 mM, pH 7.0) containing ThDP (1 mM), MgCl2 (2 mM), lysozyme (1 
mg/mL), and DNaseI (0.1 g/mL). The plates were incubated at 37 °C for 30 min and 
centrifuged (1600 g).  The supernatant was assayed for enzymatic activity (Figure 2.4).  
 
Figure 2.4 E1o Specific Screen for Alter Substrate Specificity. 
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E1o-specific activity was assessed using the external oxidizing agent 
2,6-dichlorophenolindophenol (DCPIP) (Figure 2.5); its reduction was measured at 600 
nm. The assay mixture contained: 110 L NaH2PO4 (100 mM, pH 7.0), DCPIP (0.1 mM), 
MgCl2 (2.0 mM), ThDP (1.0 mM), and 2-oxoglutarate (2.0 mM, 2-OG) or 2-oxovalerate 
(4.0 mM, 2-OV). The reaction was initiated by the addition of 40 L of supernatant, and 
active variants were identified from the disappearance of the blue color upon DCPIP 
reduction.  The endpoint absorbance was measured using the microtiter plate reader at 600 
nm at 30 °C.  A rescreen was performed to eliminate false positives. Each positive clone 
was retrieved from the master plate and it was streaked on LB agar plates containing 
chloramphenicol (100 g/mL). Single colonies from each clone were picked into a column 
of wells in a microtiter plate, and one column was reserved for the wild-type E1o. The 
rescreen was similar to the E1o assay described above. The positive clones for 2-OG or 
2-OV were sequenced using ABI BigDye Terminator chemistry on an ABI 3130xl genetic 
analyzer (Molecular Resource Facility, University of Medicine and Dentistry of New 
Jersey, Newark).  
 
N
HO
Cl
O
Cl
H
N
HO
Cl
OH
Cl
+   2H
+
   +   2e
-
2,6-dichlorophenolindophenol (Blue) Colorless  
Figure 2.5 E1 Specific Colorimetric 2,6-Dichlorophenolindophenol Reduction Reaction. 
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2.3.3 Expression and Purification of Wild Type E1o and Its Variants 
An E. coli AG1 frozen stock harboring the E1o plasmid was streaked on LB agar plates 
containing chloramphenicol (100 g/mL) and incubated at 37 °C overnight.  A single 
colony was used to inoculate 20 mL LB containing chloramphenicol (100 g/mL).  The 
overnight culture was used to inoculate 1 L of LB medium containing chloramphenicol 
(100 g/mL), thiamin hydrochloride (1.0 mM), and MgCl2 (2.0 mM).  The culture was 
induced with IPTG (1.0 mM) at OD595 = 0.5-0.8 and incubated at 30 
o
C with shaking 
overnight. The cells were centrifuged at 4400 g at 4 °C, and the pellet was stored at -20 °C. 
 All subsequent steps were carried out at 4 °C. The cells were resuspended in 20 mM 
KH2PO4 (pH 7.0) containing NaCl (0.1 M), MgCl2 (2.0 mM), ThDP (1.0 mM), 
benzamidine hydrochloride (1.0 mM), PMSF (1.0 mM), lysozyme (0.6 mg/mL) and 
incubated on ice for 20 min. The cells were sonicated for 4 min (10 s pulsar “on” and 10 s 
pulsar “off”) using the Sonic Dismembrator Model 550 (Fisher Scientific). The lysate was 
centrifuged at 30,000 g at 4 °C for 30 min. The supernatant was applied to a Ni Sepharose 
6 Fast Flow Column (GE Healthcare) that was equilibrated with KH2PO4 (20 mM, pH 7.4), 
which contained NaCl (0.1 M), MgCl2 (2 mM), ThDP (1 mM), benzamidine hydrochloride 
(1 mM). The enzyme was eluted with KH2PO4 (20 mM, pH 7.4) containing NaCl (0.5 M), 
imidazole (150 mM), MgCl2 (2.0 mM), and ThDP (1.0 mM). Fractions with enzyme were 
combined, dialyzed against KH2PO4 (20 mM, pH 7.4) containing MgCl2 (2.0 mM), ThDP 
(1.0 mM) and benzamidine hydrochloride (1.0 mM). Next, the enzyme was concentrated 
by ultrafiltration with a cutoff of 30 kDa. The purity was confirmed by SDS-PAGE. The 
E1o variants were overexpressed and purified using the procedure developed for wild-type 
E1o. Wild-type E1o and E1o variants were stored at -20 °C. 
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2.3.4 Expression and Purification of Wild-type E2o 
A single colony on the plate was used to inoculate 16 mL LB containing chloramphenicol 
(30 g/mL). Next, the overnight culture was inoculated into LB (800 mL) containing 
chloramphenicol (30 g/mL) and lipoic acid (0.3 mM), and cells were grown at 37 °C to an 
OD650 = 0.6 - 0.7. The E2o expression was induced by IPTG (0.1 mM) for 5 h at 37 °C. 
Cells were collected, washed with KH2PO4 (20 mM, pH 7.0) containing NaCl (0.15 M) and 
stored at -20 °C. 
 The E2o was purified, as was E2p [61] with some modifications.  The precipitation 
of E2o by ammonium sulfate was replaced by ultracentrifugation at 117000 g for 4 h.  E2o 
was purified using Sephacryl S-300 HR gel-filtration column equilibrated with 20 mM 
KH2PO4 (pH 7.2) containing 0.50 mM EDTA, 0.20 M NaCl, 1 mM DTT and 1 mM 
benzamidine HCl. Fractions containing E2o  were collected  and protein was precipitated 
by ultracentrifugation  as described above. The pellet was dissolved in 20 mM KH2PO4 
(pH 7.2) containing 0.50 mM EDTA, 1 mM DTT, 1 mM benzamidine HCl and 0.50 mM 
NaCl (the concentration of NaCl was increased from 0.2 M to 0.5M to keep protein 
soluble).  E2o was stored at -80 
o
C. Expression and purification of wild type E3 was carried 
out according to Wei et al. [62]. 
2.3.5 Activity and Related Measurements 
The E1-specific activity of wild type E1o and its variants was measured by monitoring the 
reduction of DCPIP at 600 nm using a Varian DMS 300 or DMS 500 spectrophotometer. 
The assay medium contained in KH2PO4 (20 mM, pH 7.0): MgCl2 (2 mM), ThDP (0.2 
mM), DCPIP (0.1 mM) and substrate [2-OG (2 mM), pyruvate (25 mM) or 2-OV (45 mM)] 
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at 30 °C. The reaction was initiated by adding the enzyme. One unit of activity is defined as 
the amount of DCPIP reduced (mol/min/mg of E1o). 
 The overall activity of the OGDHc was determined from the substrate-dependent 
reduction of NAD
+
 at 340 nm after reconstitution for 20 min at 25 °C of E1o with E2o and 
E3 at a mass ratio of 1:1:1 (mg/mg/mg) in 20 mM KH2PO4 (pH 7.2) containing 0.15 M 
NaCl. The assay medium contained:  0.1 M Tris-HCl (pH 8.0), MgCl2 (1.0 mM), ThDP 
(0.2 mM), dithiothreitol (2.6 mM), NAD
+
 (2.5 mM), and substrate [2-OG (2 mM) or 
pyruvate (25 mM) or 2-OV (45 mM)].  The reaction was initiated by the addition of CoA 
(0.13 mM). The initial steady state velocities were determined from the progress curves 
recorded at 340 nm and 30 °C. One unit of activity is defined as the amount of NADH 
produced (mol/min/mg of E1o). The reaction conditions for the hybrid E1o-E2p-E3 and 
E1p-E2o-E3 complexes were the same.  It should be noted that the E3 component is 
common to PDHc and OGDHc from E. coli [17, 18]. 
2.3.6 Circular Dichroism (CD) Measurement 
CD experiments were carried out on a Chirascan CD spectrometer (Applied Photophysics, 
Leatherhead, UK) at 30 °C by using the pyruvate and 2-OG analogs sodium 
acetylphophinate (AcP
-
) [63], methyl acetylphosphonate (MAP
-
) [64], 
propionyl-phosphinate (PP
-
), succinylphosponate (SP
2-
) and succinylphosphonate methyl 
ester (SPME
-
) (Appendix).  E1o and its variants (concentration of active centers = 20 -24 
M) in 20 mM KH2PO4 (pH 7.0) containing NaCl (0.15 M), MgCl2 (2.0 mM) and ThDP 
(0.2 mM) were titrated with substrate analogs (0.5 – 2000 M). The difference CD spectra 
were obtained by subtracting the CD spectrum of E1o or its variants in the absence of 
substrate analogs. The values of Kd were determined as described earlier [65]. 
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2.3.7 Sample Preparation for Fourier Transform Mass Spectrometric Analysis 
(FTMS) 
Electro-spray ionization FTMS was performed with an Apex-ultra 70 hybrid FTMS 
instrument from Bruker Daltonics (Billerica, MA). The E1p-E2o-E3 or E1o-E2p-E3 
hybrid complexes were reconstituted by the same method as above. Sequentially, the 
complexes were incubated for 10 min in the reaction medium containing: Tris-HCl (0.1 M, 
pH 8.0), MgCl2 (1.0 mM), ThDP (0.2 mM), dithiothreitol (2.6 mM), NAD
+
 (2.5 mM), CoA 
(0.13 mM) and 2-OG (2 mM) or pyruvate (2 mM) at 25
 o
C. To quench the reaction and 
precipitate protein an acidic quench solution consisting of 12.5% trichloroacetic acid/1 M 
HCl was added. After the acid quench, protein was removed by centrifugation at 15,700 g 
for 15 min. For control, acetyl-CoA, succinyl-CoA and CoA stock solutions were prepared 
in deionized water and diluted to 0.13 mM in acidic quench solution. Then, 50 L of each 
sample was mixed with 50 L of solvent containing 0.1 % (v/v) formic acid and 50 % 
MeOH (v/v) in deionized water. These samples were then injected into FTMS at 2 L/min; 
20 scans were acquired with a netflow rate of 1.0.      
 To further confirm the ability of E1o to accept pyruvate and use it in reductive 
acetylation of E2p, a mixture of E1o + pyruvate + lipoyl domain E2p (N-terminally 
His-tagged and purified to homogeneity on a Ni-Sepharose column) was used. Then 
quenched the mixture was quenched into acid quench solution and ran the ESI-FTMS on 
the product. Mass corresponding to reductively acetylated dihydrolipoyl domain E2p or 
succinylated dihydrolipoyl domain E2p was observed.    
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2.4 Results 
2.4.1 Screening  
Results of screening revealed that of the 352 colonies screened for His260 substitutions, 7 
were found positive with 2-OV and 61 with 2-OG. Of the 7 colonies found positive for 
2-OV, DNA sequencing revealed that all were wild-type E1o.  Of the 8 colonies screened 
positive with 2-OG, 7 were identified as wild-type E1o and one was His260Glu. This 
immediately suggests that His260 is crucial for substrate binding. At position His298, 440 
colonies were screened for 2-OG activity and 350 for 2-OV activity. DNA sequencing 
identified the His298Thr and His298Leu substitutions active with 2-OG, and the 
His298Asp and His298Val substitutions active with 2-OV. Screening for dual 
His260/His298 substitutions with 2-OG (1232 colonies) and with 2-OV (1672 colonies) 
revealed several active variants:  His260/His298Thr (with 2-OG), His260/His298Asp, 
His260/His298Thr, and His260Glu/His298Asn (with 2-OV) (Table 2.2).  
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Table 2.2 Mutations from NNS Libraries 
Screening 
Number of 
colonies 
analyzed 
Number of 
positive 
colonies 
Number of 
sequenced 
colonies 
 
Wild –type 
identified 
 
Substitutions 
His260 + 2-OG 352 61 7 6 Glu 
His260 + 2-OV 352 6 0 0 none 
His298 + 2-OG 440 154 6 3   Thr(2), Leu 
His298 + 2-OV 352 65 3 0 Gly, Asp, Val 
His260/His298 + 2-OG 1232 65 8 7 His260/Thr298 
His260/His298 + 2-OV 1672 306 7 0 
His260/Gly298(2) 
His260/Asp298(3) 
His260/Thr298(1) 
Glu260/Asn298(1) 
 
2
5
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2.4.2 The E1-specific activity  
The E1-specific activity was unaffected when E1o was reconstituted into E1o-E2o-E3 or 
E1o-E2p-E3 complexes. Similar E1-specific activity was found with 2-OG, pyruvate or 
2-OV using E1o by itself or assembled in the OGDHc or hybrid (E1o-E2p-E3) complex 
(Table 2.3 A). The activity of E1o was 24% towards pyruvate and 19% towards 2-OV 
compared to 2-OG.  The E1-specific activity in complex reconstituted from E1o and the 
E2o and E3 components (36% with pyruvate and 21% with 2-OV) remained similar to that 
with E1o by itself. Reconstitution of E1o in the hybrid complex with E2p and E3, led to an 
E1-specific activity of 34% with pyruvate and 23% with 2-OV. This indicated that 
assembly into the OGDHc or hybrid complex does not affect significantly the E1-specific 
rates (Table 2.3 A). These results gave important evidence that pyruvate and 2-OV were 
substrates for E1o, as the DCPIP reduction assay clearly indicates that decarboxylation has 
taken place. No overall activity was detected with pyruvate or 2-OV for either the OGDHc 
or the hybrid E1o-E2p-E3 complex.  The E1o-E2p-E3 hybrid complex exhibited detectable 
activity (2.2%) with 2-OG. In contrast to E1o, E1p displayed activity only with pyruvate.  
In the DCPIP assay, E1p by itself showed no activity towards 2-OG or 2-OV.  
Furthermore, there was no activity for 2-OG or 2-OV for E1p reconstituted with either E2p 
+ E3 or E2o + E3. Similar results were obtained in the overall activity assay (Table 2.3 B).   
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Table 2.3 A:  E1-specific and Reconstituted Complex Activity with E1o 
 
 
Table 2.3 B:  E1-specific and Reconstituted Complex Activity with E1p 
 
 
To provide further evidence that pyruvate is indeed a substrate for E1o, these 
studies were conducted. (1) The carboligase side reactions commonly accompany 
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ThDP-catalyzed decarboxylations. These reactions involve nucleophilic addition of the 
enamine to the carbonyl carbon of reactant or product, resulting in the formation of 
acetoin-like or acetolactate-like ligated products (Scheme 2).  
 
Scheme 2 Mechanism of Carboligase Reaction. 
 
Observation of carboligase products provides strong confirmation that 
decarboxylation of substrate had taken place. On addition of pyruvate to E1o, a negative 
CD band developed at 300 nm, indicating formation of optically active (R)-acetolactate, 
(Figure 2.6). The negative circular dichroism (CD) band at 300 nm was still present after 
removal of protein; both the sign of the band and its location are similar to those observed 
with the Glu636Ala variant of E1p ([50], confirmed on that enzyme both by CD and 
NMR).  
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Figure 2.6 Near-UV CD Spectra of E1o in The Presence of Pyruvate. The E1o (13.2 M 
Active Center Concentration) in 20 mM KH2PO4 (pH7.0) Containing 2.0 mM MgCl2 and 
0.20 mM ThDP (curve 1). CD Spectra of E1o after Addition of 4 mM Pyruvate at Different 
Times of Incubation (curves 2-10). Inset: The Dependence of the CD at 300 nm on Time of 
E1o Incubation with 4 mM Pyruvate. 
 
 Next, it was next demonstrated that the pyruvate decarboxylated by E1o could 
reductively acetylate lipoyl domain derived from E2p (LD-E2p), which could be detected 
by Fourier Transform Mass Spectrometry (FTMS). The rate constant for reductive 
acetylation of LD-E2p by (E1o + pyruvate) was 0.0056 + 0.001 s
-1
, compared to 51.7 + 5.4 
s
-1
 for (E1p + pyruvate) under the same conditions. The reductive acetylation of the 
didomain comprising lipoyl and subunit binding domains of the E2p was also 
demonstrated (not shown). Formation of succinyl-CoA by E1o-E2o-E3 and 2-OG was 
confirmed by both the isotopic pattern and m/z ratio (868.14) of a succinyl-CoA standard 
in FTMS (Figure 2.7).  Next, E1o-E2p-E3 was reacted with 2-OG to produce detectable 
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amounts of succinyl-CoA (Table 2.3 A), displaying a similar isotopic distribution with the 
standard spectrum of succinyl-CoA (Figure 2.8). 
 
 
Figure 2.7 Mass Spectrum of Succinyl-CoA Standard (top) and as Produced by 
E1o-E2o-E3 with 2-OG (bottom). 
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Figure 2.8 Mass Spectrum of Succinyl-CoA Standard (top) and as Produced by 
E1o-E2p-E3 with 2-OG (bottom). 
  
These additional experiments, in part, were carried out to also address the finding 
by Frey’s group that in the OGDHc isolated from E. coli, there is indeed found as much as 
10% E1p [54], whose presence would confound our interpretation. It needs to be 
demonstrated that the pyruvate-decarboxylating activity displayed by E1o was not an 
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artifact of the presence of E1p. The fact that all of the components of OGDHc were 
His-tagged and independently overexpressed together in the experiment above rules out 
any significant contamination from intrinsic E1p components. 
2.4.3 Effect of His260 and His298 Substitution of E1o Activity  
The effect of His260 and His298 substitutions on E1o activity was examined. Saturation 
mutagenesis data revealed that His298 could tolerate substitution. The DCPIP activity for 
the E1o variants with 2-OG was ranged from less than 1% (His298Thr) to 19% 
(His298Leu) (Table 2.4 A). The KM for 2-OG increased for some E1o variants, while the 
catalytic efficiency (kcat/KM) of all variants with 2-OG was lowered.  The catalytic 
efficiency for the best E1o variants decreased ~7-fold for His298Leu and ~17-fold for 
His260Glu/His298Asn, and was severely compromised for other variants (Table 2.4 A). 
Remarkably, the His298Asp and His298Val substitutions converted E1o to 2-OV 
dehydrogenase with activities comparable to that observed with 2-OG (Table 2.4 B). The 
His298 substitution in E1o also affected the overall OGDHc activity (Table 2.5).  The 
relative activities according to the E1-specific and overall activity assays were 
approximately paralleled. Finally, OGDHc did not show any overall activity towards 
2-OV, again implying discrimination at the E2o level. 
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Table 2.4 Effect of His298 and His260/His298 Substitutions on E1-specific Activity of 
OGDHc 
 
A: 2-Oxoglutarate as Substrate 
a E1o was from a different preparation than in Table 2.  b Not detectable above the      
 background. 
 
B: 2-Oxovalerate as Substrate 
 
.  
 
 
Substitution 
DCPIP activity 
(mol.min-1.mg-1) 
kcat 
(s
-1
) 
KM 
(mM x 10
-3
) 
kcat/KM 
(s
-1
 mM
-1
) 
none 0.620 ± 0.03
a
  2.15 ± 0.10 2.61 ± 0.376 824 
His298Leu 0.120 ± 0.028 0.415 ± 0.098 3.41 ± 0.237 122 
His298Thr 0.0018 ± 0.0001 0.0064 ± 0.0002 4.25 ±  0.160 1.5 
His298Asp nd 
b 
nd  nd nd 
His298Val 0.029 ± 0.003 0.099 ± 0.009 165 ± 6 0.60 
His260Glu/His298Asn 0.039 ± 0.004 0.134 ± 0.013 2.73 ± 0.469 49.1 
His260Glu 0.0091 ± 0.0007 0.032 ± 0.003  383 ± 35.5 0.0084 
Substitution 
DCPIP activity 
(mol.min-1.mg-1) 
kcat 
(s
-1
) 
KM 
(mM) 
kcat/KM 
(s
-1
 mM
-1
) 
none 0.022 ± 0.002 0.076 ± 0.007 16.3 ± 4.00 0.0047 
His298Leu 0.027 ± 0.003 0.094 ± 0.011 6.30 ± 0.64 0.015 
His298Thr 0.0086 ± 0.0009 0.030 ± 0.003 15.3 ± 1.00 0.0020 
His298Asp 0.357 ± 0.018 1.24 ± 0.062 7.02 ± 0.023 0.18 
His298Val 0.160 ± 0.005 0.556 ± 0.018 8.96 ± 0.005 0.062 
His260Glu/His298Asn 0.017 ± 0.0008 0.060 ± 0.003 68.4 ± 4.05 0.00088 
His260Glu 0.0039 ± 0.0001  0.014 ± 0.0003 0.12 ± 0.034 0.12 
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Table 2.5 Steady-state Kinetic Parameters for the Overall Activity of OGDHc Variants 
with 2-OG 
 
 
2.4.4 Analysis of Pre-decarboxylation Intermediate by Circular Dichroism 
CD experiments revealed formation of a pre-decarboxylation intermediate analog between 
E1o and 2-oxophosphonate and 2-oxophosphinate analogs (Figure 2.9). The Jordan group 
at Rutgers has published extensively on CD detection of ThDP-bound covalent 
intermediates on enzymes with substrate mimics derived from methyl acetylphosphonate 
(MAP) and acetylphosphinate (AcP
-
), which are analogs of pyruvate (Figure 2.9) [60, 63, 
66].  
 
Substitution 
NAD
+
 activity 
(mol.min-1.mg-1) 
kcat 
(s
-1
) 
Km 
(mM) 
kcat/Km 
(s
-1
 mM
-1
) 
none 16.6  0.44 57.5  1.57 0.09  3.61 639 
His298Leu 3.80  0.21 13.2  0.51 0.27  0.34 48.9 
His298Thr 0.26  0.01 0.90  0.02 0.23  0.04 3.91 
His298Asp 0.2  0.79  0.30 2.63 
His298Val 0.28  0.03 0.98  0.09 0.15  0.01 6.53 
His260Glu/His298Asn 0.28  0.01 0.97  0.03 0.22  0.02 4.41 
His260Glu 0.40  0.01 1.39  0.02 0.72  0.01 1.93 
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Figure 2.9 Phosphonate and Phosphinate Analogs Used in Experiments. 
 
It had been reported that succinyl phosphonate (SP
2-
) and its monomethyl 
phosphonate ester (SPME
-
), which are analogs of 2-OG, inhibit partially purified OGDHc 
complex from brain with S0.5, SP
-
 = 0.12 mM, which is in the range of values of KM, 2-OG 
=0.1-0.2 mM reported for OGDHc from different sources [67]. The inhibitory effect of 
SPME
-
 was also demonstrated for OGDHc from E. coli and pigeon breast muscle [68] and 
very recently for MenD [69]. MenD is also a thiamin diphosphate-dependent enzyme 
involved in the biosynthesis of menaquinone in bacteria. Initially, E1o was titrated with 
AcP
-
 because this analog was found to bind strongly to a number of ThDP enzymes [60]. 
CD spectra of E1o titrated with AcP
-
 revealed the generation of two CD bands: a positive 
one at 297 nm earlier assigned to the 1’,4’-iminopyrimidine tautomer (IP) of the first 
covalent intermediate and a negative one at 330 nm assigned to a Michaelis complex [66] 
(Figure 2.10).  
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Figure 2.10 Michaelis Complex and 1’,4’-Iminopyrimidine (IP)-ThDP Forms Detected by 
CD.  
 
The calculated values of Kd for AcP
-
 were 320 M (at 297 nm) and 310 M (at 330 
nm) (Figure 2.11, Table 2.6) as compared with KM, 2-OG of 90 M (Table 2.5). Later, 
SPME
-
, SP
2-
 and PP
-
, analogs for 2-OG and 2-OV, respectively, were evaluated in the CD 
experiment (Table 2.6, Figures 2.12 and 2.13).  
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Figure 2.11 Circular Dichroism Titration of E1o by Acetyl Phosphinate.  E1o (1.62 
mg/mL, Concentration of Active Centers = 15.5 M) was Titrated by AcP- (5-800 M) in 
20 mM KH2PO4 (pH 7.0) Containing 2 mM MgCl2 and 0.2 mM ThDP at 30 
o
C. Inset: 
Dependence of the Ellipticity at 297 nm on Concentration of AcP
-
. 
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Figure 2.12 Circular Dichroism Titration of E1o with Succinyl Phosphonate Methyl Ester.  
E1o (2.5 mg/ mL, Concentration of Active Centers = 23.6 M) in 20 mM KH2PO4 (pH 7.0) 
was Titrated by SPME
-
 (1-200 M) in 20 mM KH2PO4 (pH 7.0) Containing 2 mM MgCl2 
and 0.20 mM ThDP.   Inset: Dependence of Ellipticity at 300 nm on the Concentration of 
SPME
-
. 
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Figure 2.13 Circular dichroism titration of E1o with propionyl phosphinate. E1o (2.39 
mg/mL, concentration of active centers = 22.6 M) in 20 mM KH2PO4 (pH 7.0) containing 
2 mM MgCl2, 0.20 mM ThDP and 1.5 mM NaCl was titrated by PP
-
 (30-140 M).  Inset: 
Dependence of the ellipticity at 297 nm on concentration of PP
-
. 
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Table 2.6 Circular Dichroism Determination of the Formation of Pre-decarboxylation 
Intermediate between E1o Variants and Substrate Analogs  
 
 
 
These are the first CD experiments to demonstrate that on addition of substrate 
analogs, E1o forms a tetrahedral ThDP-bound pre-decarboxylation intermediate analog, 
resembling those formed from substrates. The Kd values determined are in the M range 
(SPME
- 
phosphonate monoester gives the best Kd =10 M, while the di-acid SP
2- 
is 
approximately three times weaker) demonstrating that some of the tested compounds could 
be powerful inhibitors of the OGDHc E1o component (Table 2.6). Similar CD experiments 
with the His298 E1o variants by phosphonate and phosphinate analogs of 2-oxoacids 
(Appendix) indicated that this substitution is not favorable for binding of SPME
-
, 
E1o substitution Substrate 
analogs 
CD maximum (nm) Kd (M) 
wt AcP
- 
297 320 ± 52.2 
wt MAP No band detected - 
wt PP
- 
300 39.0 ±  2.08 
wt SP
2-
  300 28.4 ± 1.12 
wt SPME
- 
297 10.1± 0.42 
His298Leu  SPME
- 
297 Not saturated 
His298Leu PP
-
 300 22.3 ± 0.98 
His298Thr SPME
- 
297 6.07 ± 0.53 
His298Thr PP
-
 297 7.00 ± 0.23 
His298Asp SPME
- 
298 659 ± 11.5 
His298Asp PP
-
 300 9.61 ± 0.20 
His298Val SPME
- 
297 144 ± 11.6 
His298Val PP
-
 297 5.17 ± 1.04 
His260Glu/His298Asn SPME 
- 
No band detected - 
His260Glu/His298Asn PP
-
 305 7.69 ± 2.50 
His260Glu SPME 
- 
No band detected - 
His260Glu PP
-
 No band detected - 
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excepting His298Thr. For the His260Glu/His298Asn variant, no CD band was detected at 
300 nm. On the other hand, His298 substitutions and the double His260Glu/His298Asn 
substitution were favorable for binding of PP
-
, which is a substrate analog for 2-OV. The 
His298Asp variant has a Kd value of 9.6 M as compared with 39 M for E1o (Figure 2.14, 
Table 2.6). In general, the Kd, PP
-
 were smaller (binding was stronger) than that for E1o, and 
Kd, PP
-
 ranged from 5.17–22.3 M (Appendix). 
 
Figure 2.14 Circular dichroism titration of His298Asp with propionyl phosphinate. The 
His298Asp E1o (2.5 mg/mL, concentration of active centers=23.8 M) in 20 mM KH2PO4 
(pH 7.0) containing 2 mM MgCl2 and 0.2 mM ThDP was titrated by PP
-
 (5-580 M). 
Dependence of the ellipticity at 300 nm on the concentration of PP
-
. 
 
2.5 Discussion  
The following could be concluded about the roles of His260 and His298 in E1o. The 
His260Glu, His298Thr, His298Val and His298Leu substitutions displayed activity with 
2-OG. The His298Asp and His298Val substitutions led to active enzyme with 2-OV, 
displaying improvement in kcat/KM in comparison to the E1o. While finding a positively 
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charged or hydrophilic side chain in its place could be anticipated, the most active variant, 
His298Leu is unexpected, with a KM comparable to that of E1o.  Being only slightly larger 
than histidine, this substitution to leucine may only fulfill a volume constraint (the van der 
Waals volumes for leucine and histidine are 124 Å
3
 and 118 Å
3
, respectively). A study on 
the active center residues of the ThDP enzyme benzoylformate decarboxylase led to a 
similar conclusion on residue His281: it could be replaced by phenylalanine or leucine 
without significant activity loss [70]. Randomization at His260 was yielded only one E1o 
variant (His260Glu) with low activity toward 2-OG and much better activity towards 
2-OV.  
The active variants identified by E1-specific assay were shown to be functionally 
competent according to their ability to form pre-decarboxylation covalent intermediate 
analogs between the ThDP and phosphono- or phosphino- analogs of 2-OG and 2-OV as 
judged by CD. The values of Kd calculated from CD data are in the M range as compared 
with reported values of KM, 2-oxoglutarate = 0.1 - 0.2 mM [67], and point to increasing binding 
potency with increasing chain length. For all His298 variants, PP
-
 was more firmly bound 
than SPME
-
, suggesting conversion of function from 2-oxoglutarate dehydrogenase to 
2-oxovalerate dehydrogenase, especially with the His298Asp and His298Val variants, 
which display relatively high activity with 2-OV. The single low activity His260Glu E1o 
variant did not display measurable CD signal with PP
-
 or SPME
-
, consistent with kinetic 
analysis. The randomization experiment, kinetic study and CD detection of covalent 
intermediate analogs provide strong evidence that His260 is crucial and indispensable for 
2-OG recognition.   
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Surprisingly, the E1o could decarboxylate 2-OV and pyruvate, in addition to 2-OG 
according to the DCPIP assay, an assay adequate to confirm decarboxylation of the 
substrates. To interrogate whether the second component would enable synthesis of 
acyl-coenzyme A derivatives from substrates accepted by the engineered E1o, hybrid 
complexes consisting of recombinant components of the E. coli OGDHc (o) and PDHc (p) 
were constructed (the E3 component is common to both). On reconstitution of E1o with 
E2o and E3 in OGDHc, the overall activity with 2-
-1
.mg E1o
-1 
and 
correlated well with recently published data on E1o [6]. No NADH production was 
detected with pyruvate or 2-OV in the E1o-E2o-E3 and E1o-E2p-E3 hybrid complexes. 
Detection of succinyl-CoA formation by mass spectrometry, and of reductively acetylated 
and succinylated LD-E2p, and of activity of the reconstituted complex by NADH kinetic 
assay, allowed us to conclude that: (1) E1o-E2o-E3 and E1p-E2p-E3 produced the 
respective acyl-CoA products and NADH; (2) E1o-E2p-E3 could produce succinyl-CoA 
from 2-OG; (3) E1p-E2o-E3 could not produce acetyl-CoA from pyruvate; and (4) E1o 
could reductively acetylate, and reductively succinylate LD-E2p. Apparently, a different 
component is the ‘gatekeeper’ for specificity for acyl-CoA formation by these two 
important multienzyme complexes in Gram-negative bacteria, E1p for pyruvate, but E2o 
for 2-OG. The ability of E1o to reductively acetylate LD-E2p, and the ability of the hybrid 
E1o-E2p-E3 to produce succinyl-CoA provide strong confirmation of this statement.  
The principal difference between this and earlier work is that here recombinant 
individual components were used, while earlier work used isolated complexes, PDHc and 
OGDHc, or their sub-complexes. Notably, Frey and associates demonstrated that 10% E1p 
co-purified with E. coli OGDHc, however, the overall activity was about 1% of that with 
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PDHc, already suggesting that the E2o also conferred substrate specificity in terms of rates 
[54]. deKok and coworkers used the OGDHc isolated from Azotobacter vinelandii and 
found modest overall activity with pyruvate, but no E1-specific activity was detected, in 
contrast to our findings [71]. ‘Promiscuous’ substrate utilization has been identified in 
several ThDP enzymes: ‘engineering’ by single amino acid substitutions has been shown 
to lead to changing both substrate and reaction specificity from a 
decarboxylase/dehydrogenase activity to carboligase-like activity in yeast pyruvate 
decarboxylase [72], E1p [50], benzoylformate decarboxylase [73, 74] among others; the 
specificity of acetohydroxyacid synthase toward pyruvate as donor has been attributed to 
hydrophobic residues [75].  
These results rule out an acid-base or hydrogen-bonding role for the residue 
His298, but confirm a hydrogen-bonding role for His260. Hence, to create complexes 
capable of accepting alternate 2-oxoacids, it will also be necessary to engineer the E2o 
active center.  
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CHAPTER 3 
THE E2 COMPONENT OF 2-OXOGLUTARATE DEHYDROGENASE 
COMPLEX FROM ESCHERICHIA COLI ALSO DICTATES SUBSTRATE 
SPECIFICITY, IN ADDITION TO THE E1 COMPONENT 
 
3.1 Introduction 
In Chapter 2, it was shown that the His298Asp E1o variant could accept the unnatural 
substrate 2-oxovalerate (2-OV) at a faster rate than the natural substrate 2-oxoglutarate 
(2-OG) (Figure 3.2).  
 
A.                                                                                       B.   
 
 
Figure 3.1 Substrates for E1o. A: 2-Oxoglutarate (Natural Substrate). B: 2-Oxovalerate 
(Unnatural Substrate). 
 
Next, His298Asp E1o was reconstituted with E2o and E3 and the multienzyme 
complex did not generate NADH in the overall reaction when using as 2-OV (Equation 
3.1).  Therefore, the overall complex failed to make the butyryl-CoA derivative. 
 
                   2-oxovalerate + CoA + NAD
+
 → butyryl-CoA +CO2 + NADH                      (3.1) 
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The E2o component consists of an amino-terminal lipoyl domain (E2oLD, 12 kDa) 
[17], followed by a peripheral E1o and E3 subunit binding domain (4 kDa) and a catalytic 
domain (E2oCD, 28 kDa) (Figure 3.1).  
 
 
Figure 3.2 Domains in E2o of OGDHc from E. coli. 
   
There are two possibilities for the failure to form NADH from 2-OV. Substrate 
specificity is determined at on two levels: reductive acylation is not occurring in the 
E2oLD or acyl transfer is not taking place from E2oCD to CoA in E2oLD (Figure 3.3). It is 
also possible that neither E2oLD nor E2oCD is capable of accepting the unnatural 
substrate. The E. coli E2oLD crystal and NMR structures have been determined [7, 8] 
(Figure 3.3). In addition, the structure of E2oCD has been solved. 
 
A.                                    B.                                   
    
Figure 3.3 A:  Ribbon Diagram of the Lipoyl Domain of E2o (E2oLD). Lys43 is Shown as 
Sticks. B: Ribbon Diagram of E2o Catalytic Domain (E2oCD). The Carboxyl-binding 
Residue (Ser333) is Shown in Magenta. The Carboxylate-binding Group (His348) is 
Shown in Red.  
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Initially, the E1o component that contains the ThDP-bound post-decarboxylation 
intermediate interacts with E2oLD, resulting in reductive acylation of the E2o-bound lipoic 
acid. It is known that the lipoyl domains from the pyruvate dehydrogenase complex 
(PDHc) and OGDHc complexes only function as efficient substrates for their respective 
E1p and E1o components [76-78]. As a result, lipoyl domains may be critical to the 
specificity of those multienzyme complexes. 
 The ability of E2oLD to undergo reductive acylation was first examined.  If E2oLD 
does not accept the substrate from E1o then E2oLD necessitates engineering.  If E2oLD 
does accept the substrate then E2oCD requires optimization. Experiments were designed to 
test these possibilities. First, E1o will be incubated with E2oLD.  It was previously shown 
that wild-type E1o accepts 2-OV (Chapter 2). Then, 2-OV will be added and electrospray 
ionization mass spectrometry (ESI-MS) will be performed to detect whether reductive 
acylation has occurred.  2-OG will be used as a positive control. Second, the E1o will be 
incubated with E2pLD from PDHc from E. coli. It should be noted that E2pLD has three 
lipoyl domains. Then, 2-OG will be added and ESI-MS will be performed to detect 
whether reductive acylation has occurred. It was previously demonstrated that E1o-E2p-E3 
was active with 2-OG in the overall reaction. When 2-OV was substituted for 2-OG, the 
reconstituted complex was inactive in the overall reaction. In addition, similar analysis was 
carried out with the E1o H298D variant, which showed higher activity toward the 
unnatural substrate 2-OV.  
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3.2 Materials  
2-Oxoglutarate and 2-oxovalerate, formic acid and methanol were from Sigma-Aldrich. 
Restriction enzymes were purchased from Invitrogen. Lipoyl protein ligase, ATP and 
DL--lipoic acid were from USB. Primers were obtained from Fisher. E. coli strain 
JW0715 containing the plasmid pCA24N encoding the OGDHc-E1 (E1o) component 
[ASKA clone (-)] was obtained from National Bio Resource Project (NIG, Japan). 
Amicon® Ultra-4 Centrifugal Filter Units are from EMD Millipore. Vivaspin 500 units are 
from GE Healthcare Biosciences, Piscataway, NJ. 
 
3.3 Methods 
3.3.1 Protein Expression and Purification 
The expression and purification of E1o, E1o H298D, E2o, and E3 were described in 
Chapter 2.  
E. coli cells from a frozen stock, which harbor the plasmid containing E2oLD, were 
streaked on LB agar plates containing chloramphenicol (30 g/mL) and incubated at 37 °C 
overnight.  A single colony was used to inoculate 20 mL LB containing chloramphenicol 
(30 g/mL).  The overnight culture was used to inoculate 1 L of LB medium containing 
chloramphenicol (30 g/mL) and lipoic acid (0.3 mM).  The culture was induced with 
IPTG (1.0 mM) when the OD600 reached 0.6 and incubated at 37 
o
C for 5 h with shaking at 
250 RPM overnight. The cells were centrifuged at 4400 g at 4 °C, and the pellets were 
stored at -20 °C. 
 All subsequent steps were carried out at 4 °C. The cells were resuspended in 
KH2PO4 (20 mM, pH 7.2) containing NaCl (0.5 M), EDTA (0.50 mM), DTT (1.0 mM), 
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benzamidine hydrochloride (1.0 mM), PMSF (1.0 mM), lysozyme (0.6 mg/mL) and 
incubated on ice for 20 min. The cells were sonicated for 4 min (10 s pulsar “on” and 10 s 
pulsar “off”) using the Sonic Dismembrator Model 550 (Fisher Scientific). The lysate was 
centrifuged at 30,000 g at 4 °C for 30 min. The supernatant was applied to a Ni Sepharose 
6 Fast Flow Column (GE Healthcare) that was equilibrated with KH2PO4 (20 mM, pH 7.2), 
which contained NaCl (0.5 M), EDTA (0.50 mM), DTT (1.0 mM), benzamidine 
hydrochloride (1 mM). The enzyme was eluted with KH2PO4 (20 mM, pH 7.2) containing 
NaCl (0.5 M), imidazole (150 mM), and EDTA (0.5 mM). Fractions with enzyme were 
combined, dialyzed against KH2PO4 (20 mM, pH 7.2) containing NaCl (0.5 M), EDTA 
(0.5 mM) and benzamidine hydrochloride (1.0 mM). Next, the enzyme was concentrated 
by ultrafiltration with a cutoff of 30 kDa. The purity was confirmed by SDS-PAGE. 
E2pLD was purified as described previously [62] except that no DL-α-lipoic acid 
was added to cell culture. 
3.3.2 Lipoylation of E2pLD  
As shown by ESI-FTMS, the purified E2oLD was fully lipoylated, while E2pLD was 
completely unlipoylated. To achieve full lipoylation of E2pLD, the lipoylation reaction for 
E2pLD was performed in vitro with E. coli lipoyl protein ligase [78]. E2pLD (50 μM) was 
incubated in ammonium bicarbonate (20 mM, pH 7.0) containing ATP (1.2 mM), MgCl2 
(1.2 mM), DL-α-lipoic acid (0.6 mM), lipoyl protein ligase (0.8 μM,) for 1 h at room 
temperature. 
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3.3.3 Reaction of the Enzyme with Substrates 
The purified proteins (E2oLD, wild-type E1o, and E1o H298D) in KH2PO4 buffer (20 mM, 
pH 7.2) and lipoylated E2pLD were dialyzed against ammonium bicarbonate (20 mM, pH 
7.0) buffer by Vivaspin 500 units (3K MWCO for E2oLD and E2pLD; 10K MWCO for 
wild-type E1o and E1o H298D). Wild-type E1o or E1o H298D (1 or 30 M) and E2oLD or 
E2pLD (30 M) were incubated in ammonium bicarbonate (20 mM, pH 7.0) containing 
MgCl2 (0.1 mM), thiamin diphosphate (ThDP, 0.05 mM) and substrate (2-OG or 2-OV, 5 
mM) for 10 min at room temperature.    
3.3.4 Measurement of the Acylation of E2oLD and E2pLD with ESI-FTMS 
Mass spectrometric analysis was carried out on a Bruker Daltonics Apex Ultra 7.0 FT-MS 
Mass Spectrometer. All protein samples were diluted into 1µM with a buffer consisting of 
a 50: 50: 0.1 (v: v: v) mixture of methanol, water and formic acid. The samples were 
introduced into the mass spectrometer through a KD Scientific KDS-100 syringe pump at a 
flow rate of 120 µL/h. Mass spectra were acquired with electrospray in the positive 
ionization mode. To achieve high accuracy in the mass measurement, the mass 
spectrometer was calibrated using Agilent ES Tuning Mix over a mass to charge ratio of 
300 to 3,000. The acquired mass spectra were analyzed and deconvoluted with Bruker 
Daltonics DataAnalysis 4.0. 
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3.4 Results and Discussion 
3.4.1 ESI-MS Analysis of E2oLD in the Reaction with E1o and 2-OV 
Here, the most abundant isotopic mass is used for mass comparison. The theoretical mass 
was calculated by Bruker Daltonics IsotopePattern 1.3, and the experimental mass was 
read from Bruker Daltonics DataAnalysis 4.0. 
As a control, it was shown by ESI-MS that E1o, E2oLD and 2-OG forms 
succinylated E2oLD (Figure 3.4). The theoretical mass difference between succinylated 
E2oLD (11523.82 Da) and E2oLD (11422.82 Da) is 101.00 Da.  The experimental value 
was 100.01 Da.  Next, E1o, E2oLD, and 2-OV were incubated together and the reaction 
mixture was analyzed by ESI-MS.  E2oLD was reductively butyrylated by E1o (Figure 
3.5). The theoretical mass difference between butyrylated E2oLD (11493.85 Da) and 
E2oLD (11422.85 Da) was 71.85 Da.  The experimental value is 71.85 Da. However, 
E1o-E2o-E3 could not produce NADH in the overall reaction with 2-OV.  Hence, the 
reaction is stopped in E2oCD, i.e., the catalytic center responsible for forming acyl-CoA 
from acyl-dihydrolipoyl-E2o would not accept the butyryl group. (Figure 3.5) 
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Figure 3.4 Mass Spectrum of Succinylated E2oLD Produced by E1o and 2-OG. 
 
Figure 3.5 Mass Spectrum of Butyrylated E2oLD Produced by E1o and 2-OV. 
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3.4.2 ESI-MS Analysis of E2oLD in the Reaction with H298 E1o and 2-OV 
It was previously shown that His298Asp E1o reconstituted with E2o-E3 produces NADH 
in the overall reaction with 2-OG. As control, His298Asp E1o, E2oLD, and 2-OG 
produced succinylated E2oLD (Figure 3.6).  The experimental value for the difference of 
succinylated E2oLD (11422.85 Da) and E2oLD (11522.86 Da) was 100.01 Da, is in 
agreement with the theoretical value. Next, His298Asp E1o, E2oLD, and 2-OV were 
incubated together and the reaction mixture was analyzed by ESI-MS.  E2oLD was 
reductively butyrylated by E1o (Figure 3.7) and the experimental value 71.05 Da, which is 
in agreement with the theoretical value. However, His298Asp E1o-E2o-E3 could not 
produce NADH in the overall reaction.  Hence, the reaction is stopped at E2oCD.   
 
Figure 3.6 Mass Spectrum of Succinylated E2oLD Produced by His298Asp E1o and 
2-OG. 
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Figure 3.7 Mass Spectrum of Butyrylated E2oLD Produced by His298Asp E1o and 2-OV. 
 
3.4.3 ESI-MS Analysis of E2pLD in the Reaction with His298Asp E1o and 2-OV 
It was previously shown E1o-E2p-E3 and His298Asp E1o-E2p-E3 were able to produce 
NADH in the overall reaction with 2-OG, but the reactions occurred at a slow rate. On the 
other hand, E1o-E2p-E3 and His298Asp E1o-E2p-E3 did not generate NADH in the 
overall reaction with 2-OV or it generate too little to be detected. 
E1o, E2pLD, and 2-OG were incubated and the reaction mixture was analyzed by 
ESI-FTMS.  E2pLD can be reductively succinylated by wild-type E1o (Figure 3.8) or by 
His298Asp E1o (Figure 3.9). 
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Figure 3.8 Mass Spectrum of Succinylated E2pLD Produced by E1o and 2-OG. 
 
 
Figure 3.9 Mass Spectrum of Succinylated E2pLD Produced by His298Asp E1o and 
2-OG. 
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E1o, E2pLD, and 2-OV were incubated and the reaction mixture was analyzed by 
ESI-FTMS.  No reductive butyrylation on E2pLD was observed with wild-type E1o 
(Figure 3.10) or with His298Asp E1o (Figure 3.11). These results further support the 
conclusions in Chapter 2.  E1o-E2p-E3 forms NADH in the overall reaction with 2-OG, 
but the complex does not form NADH with 2-OV. Hence, E2p requires engineering to 
accept unnatural substrates.  In addition, it was shown that E1p has strict substrate 
specificity for the natural substrate. This demonstrates that the E1p and E2p components 
are not a good starting point for synthesizing derivatives of CoA.  Whereas, E1o, 
His298Asp, and E2oLD have a broad specificity and only the E2oCD domain needs 
optimization.  
 
 
Figure 3.10 Mass Spectrum of the Product of a Reaction with E1o, E2pLD and 2-OV. 
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Figure 3.11 Mass Spectrum of the Product Resulting from a Reaction of His298Asp E1o, 
E2pLD and 2-OV. 
 
3.5 Conclusions 
In conclusion, E1o and His298Asp E1o can be reductively succinylate and butyrylate 
E2oLD with 2-OG and 2-OV, respectively.  These results were confirmed with ESI-FTMS. 
However, NADH production was not detected for 2-OV in the overall reaction with either 
E1o-E2o-E3 or His298Asp E1o-E2o-E3. Therefore, butyryl transfer from the lipoyl 
domain to the catalytic domain is hindered.  The E1p and E2p components from PDHc 
both require engineering to be used in the synthesis of unnatural CoA derivatives.  
However, only the E2oCD domain from OGDHc requires optimization.  Therefore, 
OGDHc or variants of OGDHc are a suitable starting point to form unnatural CoA 
derivatives. 
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CHAPTER 4 
INTERCHAIN SUCCINYL TRANSFER IN THE E2 COMPONENT OF THE 
ESCHERICHIA COLI 2-OXOGLUTARATE DEHYDROGENASE COMPLEX 
 
4.1 Introduction 
For the 2-oxoglutarate dehydrogenase complex (OGDHc) from Escherichia coli, a 
stoichiometry of 6 E1o dimers: 8 E2o trimers: 6 E3 dimers was proposed, [7, 15, 79, 80]. 
All the subunits of E2o have a single lipoyl domain (LD) and catalytic domain (CD). The 
LD is succinylated by E1o and then the succinyl group is transferred to the CD.  In the CD, 
the succinyl group is transferred to CoA producing succinyl-CoA. LD mobility is afforded 
by a flexible Ala-Pro rich linker between the LD and CD [17]. Succinyl transfer to the CD 
domain may occur through an intrachain (Figure 4.1 A) or interchain (Figure 4.1 B) 
pathway.  In this chapter, the possibility of interchain transfer will be determined.
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A. 
 
B. 
 
Figure 4.1 Succinyl Group Transfer in E. coli E2o Component. A: Intrachain Succinyl 
Group Transfer. B: Interchain Succinyl Group Transfer (Gray: Sub-complex of E. coli E1o 
and E3 Component. Green: LD of E. coli E2o Component. Orange: CD of E. coli E2o 
Component).  
 
Two E2o variants were constructed by site directed mutagenesis. 
1. The E2o domain alone (E2oLD).  This construct does not have the CD domain (Figure 
4.2)    
2. E2o with a lysine to alanine substitution at position 43 (E2oK43A). This variant is 
incompetent towards posttranslational ligation of lipoic acid. Therefore, it cannot be 
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reductively succinylated by E1o.  
                                                    
 
Figure 4.2 The Lipoyl Domain of the E2o Component of E. coli OGDHc. Lys43 Side 
Chain is shown as Sticks. 
 
A crossover experiment was designed to test this hypothesis. The overall reaction 
of OGDHc is the following (Equation 4.1). 
 
 
 
 
First, E1o, E2oLD and E3 will be reconstituted and no NADH should be produced 
in the overall reaction of OGDHc (Figure 4.3 A). Second, E1o, E2oK43A and E3 will be 
reconstituted and it is also expected not to produce NADH in the overall reaction (4.3 B). 
Finally, E2oLD will be added to the reconstituted complex that contains E1o, E2oK43A 
2-oxoglutarate + CoA + NAD
+
 → succinyl CoA + CO2 + NADH (4.1) 
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and E3. As a result, E2oLD should rescue the activity, and NADH should be produced. 
A. 
 
B. 
 
C. 
 
Figure 4.3 Crossover Experiment of Interchain Succinyl Transfer of E2o. Gray: E1o and 
E3 Components of OGDHc. Green: Reconstituted E2o Complexes. 
 
 
 
 
  
62 
 
4.2 Materials 
Thiamin diphosphate (ThDP), dithiothreitol, and isopropyl--D-thiogalactopyranoside 
(IPTG) were from U.S. Biochemical Corp. NAD
+
, coenzyme A (CoA), and succinyl 
coenzyme A (succinyl CoA), phenylmethanesulfonyl fluoride (PMSF) were from 
Sigma-Aldrich. Restriction enzymes were purchased from Invitrogen. Primers were 
procured from Fisher. 
 DNA sequencing was done at the Molecular Resource Facility of the New Jersey 
Medical School (Newark, NJ). 
 
4.3 Methods 
4.3.1 Site Directed Mutagenesis 
Site-directed saturation mutagenesis libraries were constructed using a modified 
QuikChange procedure for lipoyl domain of E2oLD and E2oK43A variants.  A typical 50 
L reaction contained 10x PfuUltra buffer, dNTP (0.2 mM) and PfuUltra DNA polymerase 
(1 unit), pCA24N encoding the E2o subunit, and primers are shown in Table 4.1.  
 
Table 4.1 List of Primers for Creating Variants of E2o  
  
No Site 5’                                            Primers                                             3’ 
1 E2oLD_F GGTAAAGAAACCAGCGCCTAATCTGAAGAGAAAGCGTCC 
2 E2oLD_R GGACGCTTTCTCTTCAGATTAGGCGCTGGTTTCTTTACC 
3 E2oK43A_F GAAATCGAAACTGACGCGGTGGTACTGGAAGTACCG 
4 E2oK43A_R CGGTACTTCCAGTACCACCGCGTCAGTTTCGATTTC 
  
63 
 
The PCR product was transformed into BL21 E. coli competent cells.  The plasmid was 
isolated and the gene was confirmed by DNA sequencing.  Frozen stock of cells were 
stored at -80 
o
C. 
4.3.2 Protein Expression and Purification 
The protein expression and purification of E1o, E2o, and E3 were described in Chapter 2. 
The E2oK43A variant was purified using same method as wild type E2o.  The purification 
of E2o LD was described in Chapter 3. The E2oK43A variant was overexpressed and 
purified using the procedure developed for wild type E2o. Purified proteins were stored at 
-20 °C. 
4.3.3 Measurement of the OGDHc Activity 
Overall activity of the OGDHc consisting of E2o and its variants was measured after 
reconstitution of the complex with independently expressed E1o and E3 components. A 
Varian DMS 300 spectrophotometer was used to monitor the 2-oxoglutrate dependent 
reduction of NAD
+
 at 340 nm. First, E2oK43A was titrated with increasing concentrations 
of E2oLD in order to determine at optimal mass ratio of E2oLD:E2oK43A (0.25:1 to 
2.5:1).  Solutions that contain E2oLD and E2oK43A were preincubated at room temperate 
for 20 min in KH2PO4 (20 mM, pH 7.2) containing NaCl (0.5 M). Then, E1o and E3 were 
added and incubated for 20 min at room temperature in the same buffer. The assay medium 
contained:  0.1 M Tris-HCl (pH 8.0), MgCl2 (1.0 mM), ThDP (0.2 mM), NAD
+
 (2.5 mM) 
and CoA (0.13 mM). The reaction was initiated by the addition of 2-OG (2.0 mM). The 
initial steady state velocities were determined from the progress curves recorded at 340 nm 
and 30 
o
C. One unit of activity is defined as the amount of NADH produced (mol/min/mg 
of complex). Overall activity for wild type OGDHc was described in Chapter 2.  The 
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overall activity of reconstituted complex containing E1o/E2oK43A/E3 E1o/E2oLD/E3 
was identical to that of wild type OGDHc. 
 
 
4.4 Results and Discussion 
4.4.1 Substitutions of Lys43Ala E2o and E2oLD Affected the Overall OGDHc 
Activities 
The overall activity of reconstituted complex, which contains E1o, E2oLD, and E3 did not 
produce detectable amounts of NADH. It is expected that when E1o, E2oK43A, and E3 are 
reconstituted together, the complex should not show NADH production.  However, NADH 
was generated (1.7%) at a low rate (Table 4.2), and this value was used as the baseline.  
4.4.2 Complementation of E2oLD with E2oK43A  
E2oK43A was titrated with increasing concentrations of E2oLD, and then E1o and E3 
were added to form a reconstituted complex (Figure, 4.4, Table 4.2).  NADH was formed 
in the overall reaction above the baseline. Maximum activity of 4.9 % above the 
background was found with a ratio 0.5 E2oLD: 1.0 E2oK43A. 
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Table 4.2 Overall OGDHc Activity of E2oLD/Lys43Ala with Various Mass Ratios 
 
 
 
 
 
 
 
 
 
Enzyme Activity (units/mg complex)  
E1o : E2o : E3 2.06 
E1o : E2oLD: E3 No Activity 
E1o : E2oK43A: E3 0.035 (1.7%) 
E1o : (E2oLD : E2oK43A = 0.25:1): E3 
 
0.046 (2.2%) 
 
E1o : (E2oLD : E2oK43A = 0.5:1): E3 
 
0.101 (4.9%) 
 
E1o : (E2oLD : E2oK43A=1:1) : E3 
 
0.093 (4.5%) 
 
E1o : (E2oLD : E2oK43A=2:1) : E3 
 
0.062 (3.0%) 
 
E1o : (E2oLD : E2oK43A=2.5:1) : E3 
 
0.074 (3.6%) 
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Figure 4.4 Activity Assay for E2o Variants Reconstituted with E1o and E3. Mixtures of 
E2oK43A and E2oLD in Various Mass Ratios were Incubated and E1o and E3 were Added 
Enabling Use of the NADH Production Assay for Overall Activity of the Complex. 
 
These results clearly show that E2oLD was capable of rescuing the crippled 
E2oK43A variant.  Therefore, an interchain mechanism is likely between two different 
E2o subunits. 
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CHAPTER 5 
CARBOLIGASE REACTION OF THE E1 COMPONENT OF THE 
2-OXOGLUTARATE DEHYDROGENASE COMPLEX  
 
5.1 Introduction 
Thiamin diphosphate (ThDP)-dependent enzymes have the potential to be used for 
chemical synthesis. These enzymes share a common feature in that they catalyze 
carboligase reactions [81, 82]. Carboligation is the native activity for several enzymes, but 
it is a side reaction for nearly all ThDP-dependent 2-oxo acid dacarboxylases. The Jordan 
research group at Rutgers-Newark have previously constructed several active site variants 
in yeast pyruvate decarboxylase (YPDC) from Saccharomyces cerevisiae and in the E1 
subunit of Escherichia coli pyruvate dehydrogenase complex (E1p), and they are capable 
of carrying out such reactions [49]. The E477Q variant of YPDC was an effective acetoin 
synthase, while the D28A or D28N variants catalyze acetolactate formation [72]. The 
E636Q and E636A E1p active site variants were also created and they also became 
acetolactate synthases [50]. Remarkably, although YPDC and E1p both catalyze 
decarboxylation of pyruvate in the first step, the opposite enantiomers of acetoin were 
produced.  
 The E1 subunit (E1o) of E. coli 2-oxoglutarate dehydrogenase complex (OGDHc) 
also catalyzes carboligation reactions. The central ThDP-bound enamine intermediate 
reacts with the electrophilic substrate, which results in the formation of acetoin-like or 
acetolactate-like ligated products (Scheme 3). 
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Scheme 3 Carboligase Reaction of ThDP-dependent Enzymes from the Central 
ThDP-bound Enamine Intermediate. 
   
The E1o component of E. coli OGDHc was reacted with substrates that vary in the 
size and functional groups to determine the versatility for carboligase reactions (Figure 
5.1).  The products were confirmed by circular dichroism (CD), nuclear magnetic 
resonance (NMR) and chiral gas chromatography (GC).  
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Figure 5.1 Substrates and Acceptors for Carboligase Reaction by E1o. 
 
5.2 Materials 
2-Oxoglutarate, 2-oxovalerate, 2-oxoisovalerate, glyoxylate, ethyl glyoxylate, and 
methylglyoxal were from Sigma-Aldrich. Restriction enzymes were purchased from 
Invitrogen.  Primers were procured from Fisher. E. coli strain JW0715 containing the 
plasmid pCA24N encoding the OGDHc-E1 (E1o) component [ASKA clone (-)] was 
obtained from National Bio Resource Project (NIG, Japan). Amicon® Ultra-4 Centrifugal 
Filter Units are purchased from EMD Millipore. 
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5.3 Methods 
5.3.1 CD Analysis  
CD experiments were carried out on a Chirascan CD spectrometer (Applied Photophysics, 
Leatherhead, UK). First, E1o (concentration of active centers = 19 M) in KH2PO4 (20 
mM, pH 7.0) containing MgCl2 (2 mM), ThDP (0.2 mM) was incubated overnight with 
2-OG (2 mM). Next, the acceptors glyoxylate (1 mM), ethyl glyoxylate (1 mM), or 
methylglyoxal (1 mM)) were added and CD spectrum was recorded (reaction 1). Similar 
reactions were performed using 2-OV (10 mM, reaction 2) or 2-OiV (10 mM, reaction 3) as 
the substrates with the acceptors. The protein was seperated from the carboligase product 
using an Amicon® Ultra-4 Centrifugal Filter Units. The filtrate was collected and the CD 
spectra were recorded between 260 nm and 400 nm. 
5.3.2 NMR Analysis   
After CD experiment, the carboligase product was extracted with chloroform. Then, 
sodium sulfate was added to remove dry the organic layer. Spectra were recorded on a 
Varian 500 MHz INOVA spectrometer at 25 
o
C.  The spectra were record by Hetalben 
Patel at Rutgers.  
5.3.3 Chiral GC Analysis   
Products were extracted from the reaction mixture with choloroform and analyzed by GC. 
GC analysis was carried out on a Varian CP-3800 gas chromatograph equipped with a 
Chiraldex B-DM chiral column (Astec, Advanced Separation Technologies, Inc.) and a 
flame ionization detector at a flow rate of 1.5 ml/min. The enantiomers were assigned 
according to their relative retention time.  It is known that the (S)-enantiomer interacts 
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more favorably with the matrix than the (R)-enantiomer. Hence, the (S)-enantiomer has a 
longer retention time. 
 
5.4 Results and Discussion 
5.4.1 Acetoin-like Product Formation by E1o with 2-OG and Glyoxylate 
No CD band was produced on reacting E1o and 2-OG showing the E1o could not form a 
carboligase product with 2-OG alone.  The active site may not be large enough to 
accommodate a free 2-OG as an acceptor or a racemic mixture was produced.  Hence, 
glyoxylate, which is a smaller acceptor, was next used.  
The reaction of E1o with 2-OG and glyoxylate (Figure 5.2) produced a negative 
CD band at 278 nm and positive band at 312 nm (Figure 5.3). The negative band indicates 
(R)-acetoin-like product formation (Figure 5.3). The product was confirmed by chiral GC 
(Figure 5.4) and 
1
H NMR (Figure 5.5). 
 
 
Figure 5.2 The Acetoin-like Product Produced from 2-OG and Glyoxylate. 
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Figure 5.3 CD Spectrum of the Compound Produced by E1o (19 M Active Center 
Concentration) in the Presence of 2-OG (2 mM), Glyoxylate (1 mM), MgCl2 (2 mM), 
ThDP (0.2 mM). 
 
 
Figure 5.4 Chiral GC of the Product from E1o with 2-OG and Glyoxylate. 
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Figure 5.5 
1
H NMR Spectrum of the Product Produced by E1o with 2-OG and Glyoxylate.  
 
5.4.2 Acetoin-like Product Formation by E1o with 2-OV and Glyoxylate 
No CD band was produced when E1o was reacted with 2-OV, showing that the enzyme 
could not form a carboligase product from 2-OV alone.  The active site may not be large 
enough to accommodate a free 2-OV as an acceptor or a racemic mixture was produced.  
Again, the acceptor glyoxylate was next tried.  
The reaction of E1o with 2-OV and glyoxylate (Figure 5.6) produced a positive CD 
band at 278 nm (Figure 5.7). The positive band indicates (S)-acetoin-like product, which 
was confirmed by chiral GC (Figure 5.8) and 
1
H NMR (Figure 5.9).  
 
 
Figure 5.6 The Acetoin-like Product Produced by E1o from 2-OV and Glyoxylate. 
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Figure 5.7 CD Spectrum of the Compound Produced by E1o (19 M Active Center 
Concentration) in the Presence of 2-OV (5 mM), Glyoxylate (10 mM), MgCl2 (2 mM), and 
ThDP (0.2 mM). 
 
 
Figure 5.8 Chiral GC of the Product Produced by E1o with 2-OV and Glyoxylate. 
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Figure 5.9 
1
H NMR Spectrum of the Product Produced by E1o with 2-OV and Glyoxylate.  
5.4.3 Acetoin-like Product Formation by E1o with 2-OiV and Glyoxylate 
No CD band was produced when E1o was reacted with 2-OiV, showing that the enzyme 
could not form a carboligase product from 2-OiV itself. The E1o active site may not be 
large enough to accommodate a free 2-OiV as acceptor or a racemic mixture was produced.  
Again, the acceptor glyoxylate was next tried.  
The reaction of E1o with 2-OiV and glyoxylate (Figure 5.10) produced a positive 
CD band at 280 nm (Figure 5.11). The positive band indicates an (S)-acetoin-like product, 
which was confirmed by chiral GC (Figure 5.12) and 
1
H NMR (data not shown).  
 
 
Figure 5.10 The Acetoin-like Product Produced from 2-OiV and Glyoxylate. 
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Figure 5.11 CD Spectrum of the Compound Produced by E1o (19 M Active Center 
Concentration) in the Presence of 2-OiV (5 mM), Glyoxylate (10 mM), MgCl2 (2 mM), 
and ThDP (0.2 mM). 
 
 
 
Figure 5.12 Chiral GC of the Product Produced by E1o with 2-OiV and Glyoxylate. 
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5.4.4 Acetoin-like Product Formation by E1o with 2-OG and Ethyl Glyoxylate 
The reaction of E1o with 2-OG and ethyl glyoxylate (Figure 5.13) produced a negative CD 
band at 280 nm (Figure 5.14). The negative band indicates an (R)-acetoin-like product, 
which was confirmed by chiral GC (Figure 5.15) and 
1
H NMR (Figure 5.16).  
 
 
Figure 5.13 The Acetoin-like Product Produced by E1o from 2-OG and Ethyl Glyoxylate. 
 
 
Figure 5.14 CD Spectrum of the Compound Produced by E1o (19 M Active Center 
concentration) in the Presence of 2-OG (2 mM), Ethyl Glyoxylate (1 mM), MgCl2 (2 mM), 
and ThDP (0.2 mM). 
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Figure 5.15 Chiral GC of the Reaction Product Formed by E1o with 2-OG and Ethyl 
Glyoxylate. 
 
 
 
Figure 5.16 
1
H NMR Spectrum of the Product Formed by E1o with 2-OG and Ethyl 
Glyoxylate.  
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5.4.5 Acetoin-like Product Formation by E1o with 2-OV and Ethyl Glyoxylate 
The reaction of E1o with 2-OV and ethyl glyoxylate (Figure 5.17) produced a weak 
positive band CD band at 280 nm (Figure 5.18). The positive band indicates 
(S)-acetoin-like product, which was confirmed by chiral GC (Figure 5.19) and 
1
H NMR 
(Figure 5.20). 
 
 
Figure 5.17 The Acetoin-like Product Produced Formed by E1o 2-OV and Ethyl 
Glyoxylate. 
 
Wavelength (nm)
260 280 300 320 340 360 380
C
D
 (
m
d
eg
)
-2
-1
0
1
2
3
 
Figure 5.18 CD Spectrum of the Compound Produced by E1o (19 M Active Center 
Concentration) in the Presence of 2-OV (5 mM), Ethyl Glyoxylate (1 mM), MgCl2 (2 mM), 
and ThDP (0.2 mM). 
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Figure 5.19 Chiral GC of the Product Formed by E1o with 2-OV and Ethyl Glyoxylate. 
 
Figure 5.20 
1
H-NMR Spectrum of the Compound Produced by E1o (19 M Active Center 
Concentration) in the Presence of 2-OV (2 mM), Ethyl Glyoxylate (1 mM), MgCl2 (2 mM), 
and ThDP (0.2 mM). 
 
  
81 
 
5.4.6 Acetoin-like Product Formation by E1o with 2-OiV and Ethyl Glyoxylate 
The reaction of E1o with 2-OiV and ethyl glyoxylate (Figure 5.21) produced a positive CD 
band at 283 nm (Figure 5.22). The positive band indicates (S)-acetoin-like product, which 
was confirmed by chiral GC (Figure 5.23) and 
1
H NMR (Figure 5.24).  
 
 
Figure 5.21 The Acetoin-like Product Produced by E1o from 2-OiV and Ethyl Glyoxylate. 
 
 
 
Figure 5.22 CD Spectrum of the Product Formed by E1o (19 M Active Center 
Concentration) in the Presence of 2-OiV (5 mM), Ethyl Glyoxylate (10 mM), MgCl2 (2 
mM), and ThDP (0.2 mM). 
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Figure 5.23 Chiral GC of the Product Formed by E1o with 2-OiV and Ethyl Glyoxylate. 
 
Figure 5.24 
1
H NMR Spectrum of the Product Formed by E1o (19 M Active Center 
Concentration) in the Presence of 2-OiV (5 mM), Ethyl Glyoxylate (10 mM), MgCl2 (2 
mM), and ThDP (0.2 mM). 
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5.4.7 Acetoin-like Product Formation by E1o with 2-OG and Methylglyoxal 
The reaction of E1o with 2-OG and methylglyoxal (Figure 5.25) produced a weak positive 
CD band at 280 nm (Figure 5.26). The positive band suggests (S)-acetoin-like product, 
which was confirmed by chiral GC (Figure 5.27) and 
1
H NMR (Figure 5.28).  
 
Figure 5.25 The Acetoin-like Product Produced from 2-OG and Methylglyoxal. 
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Figure 5.26 CD Spectrum of the Product Formed by E1o (19 M Active Center 
Concentration) in the Presence of 2-OG (2 mM), Methylglyoxal (1 mM), MgCl2 (2 mM), 
and ThDP (0.2 mM). 
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Figure 5.27 Chiral GC of the Product Formed by E1o with 2-OG and Methylglyoxal. 
 
Figure 5.28 
1
H NMR Spectrum of the Product Formed by E1o (19 M Active Center 
Concentration) in the Presence of 2-OG (2 mM), Methylglyoxal (1 mM), MgCl2 (2 mM), 
and ThDP (0.2 mM). 
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5.4.8 Acetoin-like Product Formation by E1o with 2-OV and Methylglyoxal 
The reaction of E1o with 2-OV and methylglyoxal (Figure 5.29) produced a weak negative 
CD band at 280 nm (Figure 5.30). The negative band indicates a (R)-acetoin-like product, 
which was confirmed by chiral GC (Figure 5.31) and 
1
H NMR (Figure 5.32). 
 
Figure 5.29 The Acetoin-like Product Produced from 2-OV and Methylglyoxal. 
 
 
Figure 5.30 CD Spectrum of the Product Formed by E1o (19 M Active Center 
Concentration) in the Presence of 2-OV (5 mM), Methylglyoxal (10 mM), MgCl2 (2 mM), 
and ThDP (0.2 mM). 
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Figure 5.31 Chiral GC of the Product Formed by E1o with 2-OV and Methylglyoxal. 
 
Figure 5.32 
1
H NMR Spectrum of the Product Formed by E1o (19 M Active Center 
Concentration) in the Presence of 2-OV (5 mM), Methylglyoxal (10 mM), MgCl2 (2 mM), 
and ThDP (0.2 mM). 
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5.4.9 Acetoin-like Product Formation by E1o with 2-OiV and Methylglyoxal 
The reaction of E1o with 2-OiV and methylglyoxal (Figure 5.33) produced a weak positive 
band CD band at 280 nm (Figure 5.34). The positive band indicates (S)-acetoin-like 
product, which was confirmed by chiral GC (Figure 5.35) and 
1
H NMR (Figure 5.36). 
 
 
Figure 5.33 The Acetoin-like Product Produced by E1o from 2-OiV and Methylglyoxal. 
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Figure 5.34 CD Spectrum of the Product Formed by E1o (19 M Active Center 
Concentration) in the Presence of 2-OiV (5 mM), Methylglyoxal (10 mM), MgCl2 (2 mM), 
and ThDP (0.2 mM). 
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Figure 5.35 Chiral GC of the Product Formed by E1o with 2-OiV and Methylglyoxal. 
 
 
Figure 5.36 
1
H NMR Spectrum of the Product Formed by E1o (19 M Active Center 
Concentration) in the Presence of 2-OiV (2 mM), Methylglyoxal (1 mM), MgCl2 (2 mM), 
and ThDP (0.2 mM). 
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5.4.10 Chiral GC Analysis 
E1o catalyzes the formation of acetoin-like products for all the reactions in high 
enantiomeric excess, as determined with chiral GC (Table 5.1). In addition, E1o 
demonstrates the versatility to yield products with different enantiomeric excess.  This 
enantiomer depends on the substrate and the accepter being used.  For example, E1o yields 
the (R)-enantiomer with 2-OG as the substrate and glyoxylate acceptor.  On the other hand, 
(S)-enantiomer is produced with 2-OV as the substrate and glyoxylate as acceptor. 
 
Table 5.1 Enantiomeric Excess of Acetoin-like Product Formed by OGDHc-E1o by Chiral 
GC
a 
 
 
a 
See reaction conditions in Material and Methods. 
b
 Yield  is ~ 100% for all the acetoin products. 
c
 Due to weak formation of R in GC could not calculate the ee%  but clearly shows that S is in excess. 
 
 
Substrate Acceptor Enantiomeric excess
b
 
 
2-oxoglutarate 
glyoxylate 90.4% (R) 
ethyl glyoxylate 80.5% (R) 
methyl glyoxal 82.9% (S) 
 
2-oxovalerate 
glyoxylate 96.4% (S) 
ethyl glyoxylate (S)
 c
 
methyl glyoxal 81.2% (R) 
 
2-oxoisovalerate 
glyoxylate  (S)
c
 
ethyl glyoxylate  (S)
 c
 
methyl glyoxal  (S)
 c
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5.5 Conclusions 
The ThDP-dependent enzymes are capable of catalyzing a broad range of carboligase 
reactions [73]. The variety of activities with respect to substrate range, catalytic activity, 
and enantioselectivity is a result of the protein environment surrounding ThDP. E1o of 
OGDHc from E. coli was catalyzes carboligase production as a side reaction (Scheme 3).  
The E1o is able to use a variety of substrates, which differ in size and polarity.  While the 
natural substrate 2-OG has a negatively charged carboxylate group, both, 2-OV and 2-OiV 
have a hydrophobic tail. Furthermore, 2-OV has a straight chain, while 2-OiV is branched 
(Figure 5.1). Next, E1o forms carboligase products with a variety of acceptors, which also 
contain a range of size and polarity (Figure 5.1).  Finally, the products for the carboligase 
reactions are produced with significant ee values. The trend for substrates 2-OV and 2-OiV 
reacting with the acceptors glyoxylate and ethyl glyoxylate is to produce the (S) 
enantiomer; whereas, 2-OG forms the (R) enantiomer.  This may be due to 2-OV and 
2-OiV both having hydrophobic tails, while 2-OG is hydrophilic. In contrast, there is no 
clear trend for the acceptor methylglyoxal with the three substrates.   
The Westerfeld group previously demonstrated formation of carboligase products 
using the substrate 2-OV and the acceptors acetaldehyde and glyoxylate and enzymes from 
rat and beef heart particulate fractions [83].  However, no ee was reported. In this chapter, 
recombinant E1o from E. coli was also shown to form carboligase reactions.  NMR 
confirmed product formation, and chiral GC and CD established the ee.  In addition, it was 
shown that E1o is capable of forming esters.  This is important because when the 
carboligase reactions produce -ketoacids, these products are unstable and prone to 
decarboxylation. E1o of OGDHc can catalyze carboligase reactions from a variety of 
  
91 
 
substrate and aldehyde acceptors. These results indicate that E1o is a good starting point 
for protein engineering and optimization to synthesize stable chiral intermediates for fine 
chemical synthesis.  
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APPENDIX  
CD TITRATION  
Figures A.1 to A.8 show CD titration and dependence of ellipticity of E1o variants with 
succinyl phosphonate methyl ester and propionyl phosphinate. 
 
 
Figure A.1 Dependence of Ellipticity of His298Leu with Succinyl Phosphonate Methyl 
Ester at 303nm on the Concentration of Succinyl Phosphonate Methyl Ester. 
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Figure A.2 Dependence of Ellipticity of His298Thr with Succinyl Phosphonate Methyl 
Ester at 297nm on the Concentration of Succinyl Phosphonate Methyl Ester. 
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Figure A.3 CD titration of His298Asp with Succinyl Phosphonate Methyl Ester. 
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Figure A.4 CD titration of His298Val with Succinyl Phosphonate Methyl Ester and 
Dependence of Ellipticity at 297 nm on the Concentration of Succinyl Phosphonate Methyl 
Ester. 
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Figure A.5 CD titration of His298Leu with Propionyl Phosphinate and Dependence of 
Ellipticity at 300 nm on the Concentration of Propionyl Phosphinate. 
 
 
 
 
Figure A.6 CD titration of His298Val with Propionyl Phosphinate and Dependence of 
Ellipticity at 297 nm on the Concentration of Propionyl Phosphinate. 
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Figure A.7 CD titration of His298Thr with Propionyl Phosphinate and Dependence of 
Ellipticity at 297 nm on the Concentration of Propionyl Phosphinate. 
 
 
 
 
 
Figure A.8 CD titration of His260Glu/His298Asn with Propionyl Phosphinate and 
Dependence of Ellipticity at 305 nm on the Concentration of Propionyl Phosphinate.
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